Functional observation after morphine withdrawal: effects of SJP-005.

Joris C VersterAndrew ScholeyThomas A DahlJacqueline M Iversen

Published in: Psychopharmacology (2021)

Compared to placebo, SJP-005 significantly reduced the incidence and duration of discontinuation-induced morphine withdrawal symptoms when treatment was initiated 2 days before morphine cessation.

Keyphrases

high glucose
risk factors
diabetic rats
randomized controlled trial
endothelial cells
drug induced
oxidative stress
depressive symptoms